Spironolactone
Drug - Spironolactone
The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Spironolactone
Multiple ingredients are in alphabetical order.
Strength -
25MG
The potency of the active ingredient(s), Spironolactone. May repeat for multiple part products.
Applicant -
ASCOT
The firm name holding legal responsibility for Spironolactone. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
087687
The FDA assigned number to Spironolactone. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Spironolactone. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Oct 20, 1982
The date Spironolactone was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Spironolactone. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Spironolactone is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Spironolactone.
Spironolactone
|
